Percutaneous cardiopulmonary support for high-risk angioplasty.
Crit Care Nurs Q
; 20(4): 16-28, 1998 Feb.
Article
en En
| MEDLINE
| ID: mdl-9496023
ABSTRACT
Treatment of patients with coronary artery disease with severe left ventricular dysfunction (EF less than 25%) presents a special challenge to the health care team. The ability to revascularize coronary artery lesions using percutaneous transluminal coronary angioplasty is limited because of the risk of acute vessel closure, which can result in hemodynamic collapse, myocardial infarction, and the need for emergent coronary bypass surgery. These patients may not survive long enough to undergo emergency open-heart surgery if acute vessel closure occurs. Percutaneous cardiopulmonary support (PCPS), initiated in the catheterization laboratory before coronary revascularization, can provide the hemodynamic support needed to allow the patient to tolerate the high-risk procedure. This article describes the PCPS procedure at Washington Adventist Hospital, Takoma Park, MD, and includes the clinical applications, risks and benefits, and implications for the critical care nurse.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Puente Cardiopulmonar
/
Angioplastia
Tipo de estudio:
Etiology_studies
Límite:
Humans
Idioma:
En
Revista:
Crit Care Nurs Q
Asunto de la revista:
ENFERMAGEM
/
TERAPIA INTENSIVA
Año:
1998
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
EEUU
/
ESTADOS UNIDOS
/
ESTADOS UNIDOS DA AMERICA
/
EUA
/
UNITED STATES
/
UNITED STATES OF AMERICA
/
US
/
USA